Efficacy and Safety of Moxibustion for Menopausal Obesity: A Multicentre, Randomized, Controlled Trial Protocol

Benlu Yu, Wei Huang, Yingrong Zhang, Jiajie Wang, Chen Xia, YanJi Zhang, Hongjie Xia, Yaxin Hu, Yingyue Rao, Zhongyu Zhou, Benlu Yu, Wei Huang, Yingrong Zhang, Jiajie Wang, Chen Xia, YanJi Zhang, Hongjie Xia, Yaxin Hu, Yingyue Rao, Zhongyu Zhou

Abstract

Background. In the past, moxibustion has been widely used to treat endocrine system disorders, but evidence of its effectiveness is scarce at this point. The aim of this multicenter, randomized, controlled trial is to evaluate the efficacy and safety of treating menopausal obesity with moxibustion. Methods/Design. There are six centers taking part in this randomized, controlled, parallel trial. A total of 216 patients with menopausal obesity will be randomly divided into two equal groups: the "moxibustion for harmonization of Yin and Yang" group and the gentle moxibustion group. A 12-week study period with moxibustion will be preceded by a 1-week baseline, followed by a 12-week follow-up. We will conduct an interim analysis to determine whether or not the treatment is efficacious and safe after 216 participants have completed a 12-week treatment period. Evaluations will be conducted at weeks 0, 4, 8, 12, 18, and 24. The main outcome is waist circumference (WC), and the rate of WC reduction will be compared to the baseline. An intention-to-treat analysis will be performed with a two-sided P value of <0.05 considered significant. Participants who withdraw from the trial will be analyzed according to the intention-to-treat formula (ITT). Discussion. These results will be used to support selecting the right moxibustion prescription and guiding the improvement of clinical efficacy. This trial will provide convincing evidence of moxibustion's effectiveness and safety in the treatment of obesity by "moxibustion for harmonization of Yin and Yang," which will be conducive to the promotion and clinical application of the theory of "moxibustion for harmonization of Yin and Yang." Trial Registration. This trial is registered with Clinical Trials.gov: NCT04943705 (registered on June 27, 2021).

Conflict of interest statement

The authors declare no conflicts of interest.

Copyright © 2022 Benlu Yu et al.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
Locations of acupoints in the “moxibustion for harmonization of Yin and Yang” group.
Figure 3
Figure 3
Locations of acupoints in the gentle moxibustion group.
Figure 4
Figure 4
Study schedule. IWQOL-Lite, the impact of weight on quality of life questionnaire; SF-36, the MOS item short from health survey; TCM, Traditional Chinese Medicine.

References

    1. Bray G. A., Frühbeck G., Ryan D. H., Wilding J. P. H. Management of obesity. The Lancet . 2016;387(10031):1947–1956. doi: 10.1016/s0140-6736(16)00271-3.
    1. Afshin A., Forouzanfar M. H., Reitsma M. B., et al. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine . 2017;377:13–27. doi: 10.1056/NEJMoa1614362.
    1. Maffetone P. B., Rivera-Dominguez I., Laursen P. B. Overfat and underfat: new terms and definitions long overdue. Frontiers in Public Health . 2016;4 doi: 10.3389/fpubh.2016.00279.e00279
    1. WHO. WHO obesity and overweight fact sheet no 311. 2013. .
    1. Dwivedi A. K., Dubey P., Cistola D. P., Reddy S. Y. Association between obesity and cardiovascular outcomes: updated evidence from meta-analysis studies. Current Cardiology Reports . 2020;22(4):p. 25. doi: 10.1007/s11886-020-1273-y.
    1. Kleinert S., Horton R. Obesity needs to be put into a much wider context. The Lancet . 2019;393(10173):724–726. doi: 10.1016/s0140-6736(18)33192-1.
    1. Liu B., Du Y., Wu Y., Snetselaar L. G., Wallace R. B., Bao W. Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011-18: population based study. BMJ . 2021;372:p. n365. doi: 10.1136/bmj.n365.
    1. Scully T. Public health: society at large. Nature . 2014;508(7496):S50–S51. doi: 10.1038/508s50a.
    1. Randolph J. F., Crawford S., Dennerstein L., et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. The Journal of Clinical Endocrinology & Metabolism . 2006;91(8):3034–3040. doi: 10.1210/jc.2006-0243.
    1. Thurston R. C., Sowers M. R., Sternfeld B., et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women’s health across the nation. American Journal of Epidemiology . 2009;170(6):766–774. doi: 10.1093/aje/kwp203.
    1. Ren B., Liu Z., Xu B. Effect of acupuncture and moxibustion on the treatment of obese women with menopause syndrome. Journal of Chinese Acupuncture and Moxibustion . 2012;32(10):871–876.
    1. Hartz A., He T., Rimm A. Comparison of adiposity measures as risk factors in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism . 2012;97(1):227–233. doi: 10.1210/jc.2011-1151.
    1. Protani M., Coory M., Martin J. H. Effect of obesity on survival of women with breast cancer: Systematic review and meta-analysis. Breast Cancer Research and Treatment . 2010;123(3):627–635. doi: 10.1007/s10549-010-0990-0.
    1. Garvey W. T., Mechanick J. I., Brett E. M., et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice . 2016;22(3):1–203. doi: 10.4158/.
    1. Dalle Grave R., Calugi S., El Ghoch M. Lifestyle modification in the management of obesity: achievements and challenges. Eating and Weight Disorders . 2013;18(4):339–349. doi: 10.1007/s40519-013-0049-4.
    1. Khera R., Murad M. H., Chandar A. K., et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta‐analysis. JAMA . 2016;315(22):2424–2434. doi: 10.1001/jama.2016.7602.
    1. Gloy V. L., Briel M., Bhatt D. L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ . 2013;347:p. 5934. doi: 10.1136/bmj.f5934.
    1. Parr C. L., Batty G. D., Lam T. H., et al. Asia pacifc cohort studies collaboration the burden of overweight and obesity in the asia–pacifc region. Obesity Reviews . 2007;8:191–196.
    1. Hsieh C. H., Tseng C. C., Shen J. Y., Chuang P. Y. Randomized controlled trial testing weight loss and abdominal obesity outcomes of moxibustion. BioMedical Engineering Online . 2018;17(S2):p. 149. doi: 10.1186/s12938-018-0571-8.
    1. Vickers A., Zollman C. C. ABC of complementary medicine: acupuncture. BMJ . 1999;319(7215):973–976. doi: 10.1136/bmj.319.7215.973.
    1. Li Y., Wang D., Ping X., et al. Local hyperthermia therapy induces browning of white fat and treats obesity. Cell . 2022;185(6):949–966. doi: 10.1016/j.cell.2022.02.004.
    1. Sowers M. R., Greendale G. A., Bondarenko I., et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporosis International . 2003;14(3):191–197. doi: 10.1007/s00198-002-1329-4.
    1. Furuhashi M., Kawai H., Suganuma N. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Archives of Gynecology and Obstetrics . 2004;269(3):192–195. doi: 10.1007/s00404-003-0532-7.
    1. Zhang H. W., Lin Z. X., Cheung F., Cho W. C. S., Tang J. L. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. Cochrane Database of Systematic Reviews . 2018;11 doi: 10.1002/14651858.CD010559.pub2.CD010559
    1. Chen X. H., Liu Y. X., Wang H., Zhang D. Y. Comparative study on the effect of acupuncture at “Zusanli” and “Guanyuan” acupoints on immune function in Rats with Yang deficiency. Zhong Guo Zhen Jiu . 2000;09:555–557.
    1. Chan A. W., Tetzlaff J. M., Gotzsche P. C., et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ . 2013;346 doi: 10.1136/bmj.e7586.e7586
    1. Moher D., Hopewell S., Schulz K. F., et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ . 2010;340:p. c869. doi: 10.1136/bmj.c869.
    1. Garvey W. T., Mechanick J. I., Brett E. M., et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice . 2016;22(7):842–884. doi: 10.4158/ep161356.esgl.
    1. Xie X., Kong B. H., Duan T. Gynecology and Obstetrics . Beijing, China: People’s Medical Publishing House; 2018.
    1. World Federation of Chinese Medicine Societies. International TCM Clinical Practice Guide for Menopausal Syndrome . Beijing, China: World Federation of Chinese Medicine Societies; 2020.
    1. Tronieri J. S., Wadden T. A., Walsh O. A., et al. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: a randomized placebo-controlled pilot trial. Metabolism . 2019;96:83–91. doi: 10.1016/j.metabol.2019.03.005.
    1. China Standard Press. Name and Location of Acupoints . Beijing, China: China Standard Press; 2006.
    1. NCD Risk Factor Collaboration NCD-RisC. Trends in adult bodymass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population based measurement studies with 19.2 million participants. Lancet . 2016;387(10026):1377–1396. doi: 10.1016/S0140-6736(16)30054-X.
    1. Wang L., Zhou B., Zhao Z., et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18. The Lancet . 2021;398(10294):53–63. doi: 10.1016/s0140-6736(21)00798-4.
    1. Wang H. F., Chen L., Xie Y., et al. Electroacupuncture facilitates M2 macrophage polarization and its potential role in the regulation of inflammatory response. Biomedicine & Pharmacotherapy . 2021;140(7496) doi: 10.1016/j.biopha.2021.111655.111655
    1. Kim S. Y., Shin I. S., Park Y. J. Effect of acupuncture and intervention types on weight loss: a systematic review and meta-analysis. Integrative Medicine Research . 2020;9(11) doi: 10.1016/j.imr.2020.100523.
    1. Wang J. J., Huang W., Wei D., Yang T. Y., Zhou Z. Y. Comparison of therapeutic effects of electroacupuncture and acupoint catgut embedding in reducing serum leptin and insulin levels in simple obesity patients. Zhen Ci Yan Jiu . 2019;44(1):57–61. doi: 10.13702/j.1000-0607.170768.
    1. Garcia-Vivas J. M., Galaviz-Hernandez C., Fernandez-Retana J., et al. Transcriptomic profiling of adipose tissue in obese women in response to acupuncture catgut embedding therapy with moxibustion. Journal of Alternative & Complementary Medicine . 2016;22(8):658–668. doi: 10.1089/acm.2015.0200.
    1. Koh Y. J., Lee J. H., Park S. Y. Moxibustion-simulating bipolar radiofrequency suppresses weight gain and induces adipose tissue browning via activation of UCP1 and FGF21 in a mouse model of diet-induced obesity. Evidence-based Complementary and Alternative Medicine . 2018;2018:1–12. doi: 10.1155/2018/4737515.4737515
    1. Su F. F., Gao J. Y., Wang G. Y., Chen R. Y., Wang Y. S., Zhang H. F. Effect of moxibustion at 45°C on blood lipid in hyperlipidemia rats. Zhong Guo Zhen Jiu . 2019;39(2):180–184.
    1. Chen Z., Wu Z., Li C. Different moxibustion process to hyperlipidemia lipid regulation. Zhong Guo Zhen Jiu . 2012;32(11):995–999.
    1. Ford E. S., Maynard L. M., Li C. Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA . 2014;312(11):1151–1153. doi: 10.1001/jama.2014.8362.
    1. Lean M. J., Han T. S. Waist worries. The American Journal of Clinical Nutrition . 2002;76(4):699–700. doi: 10.1093/ajcn/76.4.699.
    1. Hu F. B. Obesity Epidemiology . Oxford, UK: Oxford University Press; 2008.
    1. Sarri G., Davies M., Lumsden M. A. Diagnosis and management of menopause: summary of NICE guidance. BMJ . 2015;351:p. h5746. doi: 10.1136/bmj.h5746.
    1. Ferreira P. L. Development of the Portuguese version of MOS SF-36. Part I--Cultural and linguistic adaptation. Acta Med Port . 2000;13(1-2):55–66.
    1. Kolotkin R. L., Crosby R. D., Kosloski K. D., Williams G. R. Development of a brief measure to assess quality of life in obesity. Obesity Research . 2001;9(2):102–111. doi: 10.1038/oby.2001.13.
    1. Lan Y., Huang Y., Song Y., et al. Prevalence, severity, and associated factors of menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study in southeast China. Menopause . 2017;24(10):1200–1207. doi: 10.1097/gme.0000000000000906.
    1. Liu P., Ji Y., Yuen T., et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature . 2017;546(7656):107–112. doi: 10.1038/nature22342.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever